Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via β2 integrin

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 6, 2004, Pages 594-600

  Saito, Keiko ^a   Nagata, Makoto ^a   Kikuchi, Izumi ^a   Sakamoto, Yoshio ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b The Mutualaid Association of Public School Teachers)   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 4 INTEGRIN ANTIBODY; BETA 2 INTEGRIN ANTIBODY; BETA2 INTEGRIN; EOSINOPHIL PROTEIN X; LEUKOTRIENE D4; PRANLUKAST; PROTEIN ANTIBODY; SUPEROXIDE; UNCLASSIFIED DRUG; BETA INTEGRIN;

ADULT; ARTICLE; ASTHMA; BLOOD CULTURE; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; MALE; PARAMETER; PRIORITY JOURNAL; UMBILICAL VEIN; CELL MOTION; DEGRANULATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; SECRETION; VASCULAR ENDOTHELIUM;

ADULT; CELL DEGRANULATION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; FEMALE; HUMANS; INTEGRIN BETA CHAINS; LEUKOTRIENE D4; MALE; SUPEROXIDES;

EID: 10344253296     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61269-0     Document Type: Article

References (41)

1. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000;105:651-663.
2. Weller PF. Human eosinophils. J Allergy Clin Immunol. 2000;100:283-287.
3. Bochner BS. Cellular adhesion and its antagonism. J Allergy Clin Immunol. 1997;100:581-585.
4. Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev. 2001;179:163-172.
5. Sedgwick JB, Nagata M. Mechanism of eosinophil activation. In: Busse WW, Holgate ST, editors. Asthma & Rhinitis. 2nd ed. Oxford, England: Blackwell Science; 2000:373-393.
6. Lewis RA, Austen KF, Soberma RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990;323:645-655.
7. Hamann KJ, Douglas I, Moqbel R. Eosinophil mediators. In: Busse WW, Holgate ST, editors. Asthma & Rhinitis. 2nd ed. Oxford, England: Blackwell Science; 2000:393-428.
8. Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med. 1994;121:684-697.
9. 4 and granulocytes infiltration into asthmatic airways. Lancet. 1993;341:989-990.
10. Diamant Z, Hiltermann JT, Van Rensen EL, et al. The effect of inhaled leukotriene D4 and methacholine on cell differentials in sputum from patients with asthma. Am J Respir Crit Care Med. 1997;155:1247-1253.
11. 4 effects on human eosinophil and neutrophils motility in vitro. J Leukoc Biol. 1994;55:183-191.
12. Lee E, Robertson T, Smith J, Kilfeather S. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med. 2000;161:1881-1886.
13. Nakamura Y, Hoshino M, Sim JJ, Ishii K, Hosaka K, Sakamoto T. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma. Thorax. 1998;53:835-841.
14. Pizzichini E, Leff JA, Reiss TF, et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized controlled trial. Eur Respir J. 1999;14:12-18.
15. Yoshida S, Ishizaki Y, Shoji T, et al. Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy. 2000;30:1008-1014.
16. 4 upregulates eosinophil adhesion via the cysteinyl leukotriene 1 receptor. J Allergy Clin Immunol. 2002;109:676-680.
17. Fregonese L, Silvestri M, Sabatini F, Rossi GA. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism. Clin Exp Allergy. 2002;32:745-750.
18. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines, III: effect of the chemokine RANTES. J Immunol. 1994;153:2153-2160.
19. Yamamoto H, Sedgwick JB, Busse WW. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol. 1998;161:971-977.
20. Nagata M, Sedgwick JB, Kita H, Busse WW. Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol. 1998;19:158-166.
21. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol. 1994;152:5457-5467.
22. 2 integrin. Immunology. 2000;101:412-418.
23. Nagata M, Sedgwick JB, Vrtis R, Busse WW. Endothelial cells upregulate eosinophil superoxide generation via VCAM-1 expression. Clin Exp Allergy. 1999;29:550-561.
24. Nagata M, Yamamoto H, Tabe K, Sakamoto Y. Eosinophil transmigration across VCAM-1-expressing endothelial cells is upregulated by antigen-stimulated mononuclear cells. Int Arch Allergy Immunol. 2001;125(Suppl):7-11.
25. Nagata M, Sedgwick JB, Bates ME, Kita H, Busse WW. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol. 1995;155:2194-2202.
26. Pedersen KE, Bochner BS, Undem BJ. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. J Pharmacol Exp Ther. 1997;281:655-662.
27. Suzuki M, Kato M, Kimura H, Fujii T, Morikawa A. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (Pranlukast; ONO-1078). J Asthma. 2003;40:395-404.
28. Smith LJ, Shamsuddin M, Sporn PH, Denenburg M, Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med. 1997;22:1301-1307.
29. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma [letter]. Lancet. 1999;354:482-483.
30. Bradley JR, Johnson DR, Pober JS. Endothelial activation by hydrogen peroxide: selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am J Pathol. 1993;142:1598-1609.
31. Sellak H, Fanzine E, Hakims J, Pasquire C. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood. 1994;83:2669-2677.
32. 2-induced increase in endotheliai permeability. Am J Physiol. 1996;270:L973-L978.
33. Fraticelli A, Serrano CV Jr, Bochner BS, Capogrossi MC, Zweier JL. Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. Biochem Biophys Acta. 1996;1310:251-259.
34. 1 receptors in human eosinophils. Int Arch Allergy Immunol. 2002;129:67-75.
35. Kita H, Abu-Ghazaleh Ki, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol. 1995;154:4749-4758.
36. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 (CysLT2) receptor. J Biol Chem. 2000;275:30531-30536.
37. Pavord ID, Ward R, Woltman G, Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med. 1999;160:1905-1909.
38. Macfarlane AJ, Dworski R, Sheller JR, Pavord ID, Kay AB, Barnes NC. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med. 2000;161:1553-1558.
39. Creticos PS, Peters SP, Adkinson NF, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984;310:1626-1630.
40. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis. 1990;142:112-119.
41. 4 in blood of asthmatic children. Biochem Biophys Res Commun. 1985;130:486-492.